HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingchun Miao Selected Research

Estazolam (ProSom)

1/2020The Clinical Effectiveness of Cognitive Behavioral Therapy for Patients with Insomnia and Depression: A Systematic Review and Meta-Analysis.
12/2019Clinical effectiveness of Tui Na for insomnia compared with estazolam: A systematic review and meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingchun Miao Research Topics

Disease

2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020 - 12/2019
1Chronic Obstructive Pulmonary Disease (COPD)
07/2022
1Lung Diseases (Lung Disease)
07/2022
1Dizziness (Lightheadedness)
12/2019
1Alzheimer Disease (Alzheimer's Disease)
09/2016
1Parkinson Disease (Parkinson's Disease)
08/2014
1Mitochondrial Diseases (Mitochondrial Disease)
08/2014
1Leukemia
01/2012

Drug/Important Bio-Agent (IBA)

2Estazolam (ProSom)FDA LinkGeneric
01/2020 - 12/2019
1MicroRNAs (MicroRNA)IBA
07/2022
1AntagomirsIBA
07/2022
1SodiumIBA
07/2022
1Pharmaceutical PreparationsIBA
07/2022
1Eosine Yellowish-(YS) (Eosin)IBA
07/2022
1Hematoxylin (Haematoxylon)IBA
07/2022
1LipopolysaccharidesIBA
07/2022
1LuciferasesIBA
07/2022
1SmokeIBA
07/2022
1zopiclone (Zop)IBA
01/2020
1Hypnotics and Sedatives (Sedatives)IBA
01/2020
1BenzodiazepinesIBA
01/2020
1Amyloid beta-PeptidesIBA
09/2016
1Cytochromes c (Cytochrome c)IBA
08/2014
1NeurotoxinsIBA
08/2014
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
08/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2014
1harringtoninIBA
01/2012
1AlkaloidsIBA
01/2012
1HomoharringtonineIBA
01/2012

Therapy/Procedure

1Therapeutics
12/2019